Bioverativ Inc. (BIVV) Tops Q4 Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bioverativ Reports Fourth Quarter and Full Year 2017 Performance
February 13, 2018 4:15 PM ESTFull year 2017 year-over-year revenues up 31.7% Fourth quarter revenues up 28.3% year-over-year Full year 2017 GAAP operating margin of 38.3%; Non-GAAP operating margin of 46.5% Full year cash flows from operations of $591 million
WALTHAM, Mass.--(BUSINESS WIRE)-- Bioverativ Inc. (NASDAQ: BIVV) today reported financial results for the fourth quarter and full year of 2017.
Key financial results include:
... More